Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background: A comparison across trials conducted over several decades suggested superior efficacy of tricyclic antidepressants (TCAs) over selective serotonin-reuptake inhibitors (SSRIs). However, this outcome may reflect a selective secular decline of responses after randomization to placebo. Remaining uncertainty encouraged direct comparison of the drug-types in trials involving randomized, head-to-head comparisons. Methods: We systematically identified reports of randomized trials of TCAs versus SSRIs for major depression in several digital databases, and applied standard meta-analytic and multiple-factor regression methods to analyze and pool the findings. Results: In 89 head-to-head trials, there was no detectable overall difference in responder rates or percent-improvement between TCAs and SSRIs. In addition to non-difference between drug-types, outcomes were unrelated to reporting-year, trial-size or nominal duration, proportion of women participants, initial depression ratings, rating scales, subjects/arm, imipramine-equivalent mg/day drug dose, or dropout rate. Trial size and duration increased significantly over the years 1980–2016. Conclusions: Previous evidence suggesting superior benefits of TCAs over SSRIs for the treatment of acute major depression is probably an artifact of a selective secular decline in responses to placebo, as no difference was found in a large series of direct comparisons of these antidepressant-types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561 · cited 1×
“…drugs within classes of psychotropic agents (antidepressants, antipsychotics, antimanics), as is reflected in largely overlapping confidence intervals among responses associated with particular agents (Baldessarini, 2013; Leucht et al., 2013; Undurraga and Baldessarini, 2012; Yildiz et al., 2015).”
BackgroundAnderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940 · cited 4×
“Such a conclusion, based on head-to-head comparisons, accords with earlier reviews addressing the same question (Anderson, 2000; Arroll et al., 2005; Freemantle et al., 2000; Kasper et al., 1992; MacGillivray et al., 2003; Song et al., 1993; Steffens et al., 1997).”
BackgroundMethodResultInfluentialPacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., Post, R. M., Berk, M., Goodwin, G. M., Sachs, G. S., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020185 · Cited by 770 · cited 1×
“We excluded reports involving special populations, such as juvenile or geriatric patients, those with major general medical or neurological conditions, or including ≥10% with bipolar depression (with uncertain antidepressant responses (Pacchiarotti et al., 2013)), dysthymia, or other diagnoses.”
BackgroundSelf-citationSelective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399 · cited 4×
“Such a conclusion, based on head-to-head comparisons, accords with earlier reviews addressing the same question (Anderson, 2000; Arroll et al., 2005; Freemantle et al., 2000; Kasper et al., 1992; MacGillivray et al., 2003; Song et al., 1993; Steffens et al., 1997).”
BackgroundResultInfluentialBaldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Self-citationArroll, B. (2005) · The Annals of Family Medicine · doi:10.1370/afm.349 · Cited by 351 · cited 4×
“Such a conclusion, based on head-to-head comparisons, accords with earlier reviews addressing the same question (Anderson, 2000; Arroll et al., 2005; Freemantle et al., 2000; Kasper et al., 1992; MacGillivray et al., 2003; Song et al., 1993; Steffens et al., 1997).”
BackgroundResultInfluentialMacGillivray, S., Arroll, B., Hatcher, S., Ogston, S., Reid, I., Sullivan, F., Williams, B., & Crombie, I. (2003) · BMJ · doi:10.1136/bmj.326.7397.1014 · Cited by 265 · cited 4×
“Such a conclusion, based on head-to-head comparisons, accords with earlier reviews addressing the same question (Anderson, 2000; Arroll et al., 2005; Freemantle et al., 2000; Kasper et al., 1992; MacGillivray et al., 2003; Song et al., 1993; Steffens et al., 1997).”
BackgroundResultInfluentialMania associated with antidepressant treatment: comprehensive meta‐analytic review
Tondo, L., Vázquez, G., & Baldessarini, R. J. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2009.01514.x · Cited by 256 · cited 1×
“Possibly greater antidepressant efficacy of TCAs would accord with observations indicating that risk of excessive mood-elevation or switching in adults from depression to mania or hypomania may be greater with TCAs than SSRIs (Tondo et al., 2010).”
BackgroundSelf-citationFurukawa, T. A., Cipriani, A., Atkinson, L. Z., Leucht, S., Ogawa, Y., Takeshima, N., Hayasaka, Y., Chaimani, A., & Salanti, G. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30307-8 · Cited by 219 · cited 4×
“…may have been an artifact of selective decreases in response rates among depressed subjects randomized to placebo-treatment, whereas responses to active drugs showed little change over the past several decades (Furukawa et al., 2016; Schalkwijk et al., 2014; Undurraga and Baldessarini, 2012).”
BackgroundResultInfluentialYildiz, A., Nikodem, M., Vieta, E., Correll, C. U., & Baldessarini, R. J. (2015) · Psychological Medicine · doi:10.1017/s0033291714001305 · Cited by 128 · cited 2×
“With striking consistency, meta-analytic averaging has encountered difficulties in demonstrating differences in efficacy between specific drugs within classes of psychotropic agents (antidepressants, antipsychotics, antimanics), as is reflected in largely overlapping confidence intervals among responses associated wit…”
BackgroundSelf-citation
Cited by
Malhi, G. S., & Mann, J. J. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31948-2 · Cited by 4,099
The Role of Exercise in Preventing and Treating Depression
Schuch, F. B., & Stubbs, B. (2019) · Current Sports Medicine Reports · doi:10.1249/jsr.0000000000000620 · Cited by 264
The Deceptive Manifestations of Treatment Resistance in Depression: A New Look at the Problem
Fava, G. A., Cosci, F., Guidi, J., & Rafanelli, C. (2020) · Psychotherapy and Psychosomatics · doi:10.1159/000507227 · Cited by 48
Zimmerman, M., & Lin, S.-Y. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115162 · Cited by 4
Metadata
- Authors
- Undurraga, J., & Baldessarini, R. J.
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2017-06-21
- Volume
- 31
- Issue
- 9
- Pages
- 1184-1189
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2661742777
- Cited by
- 49
- References
- 11
- FWCI
- 0.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis. https://app.cochat.ai/papers/10.1177/0269881117711709
- The paper
- Undurraga, J., & Baldessarini, R. J. (2017). Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis. Journal of Psychopharmacology. https://doi.org/10.1177/0269881117711709
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.